Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
Abroad (travel likely)RecruitingPHASE1
Conditions
Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Triumpharma Clinical Research Unit at AlEssra Hospital, Amman, Jordan
Contact: Study coordinator (Musa Hadidi, Principal Investigator, MD) · s.mahmoud@triumpharma.com · +962 6 5350582